Literature DB >> 2047879

Identification of p53 as a sequence-specific DNA-binding protein.

S E Kern1, K W Kinzler, A Bruskin, D Jarosz, P Friedman, C Prives, B Vogelstein.   

Abstract

The tumor-suppressor gene p53 is altered by missense mutation in numerous human malignancies. However, the biochemical properties of p53 and the effect of mutation on these properties are unclear. A human DNA sequence was identified that binds specifically to wild-type human p53 protein in vitro. As few as 33 base pairs were sufficient to confer specific binding. Certain guanines within this 33-base pair region were critical, as methylation of these guanines or their substitution with thymine-abrogated binding. Human p53 proteins containing either of two missense mutations commonly found in human tumors were unable to bind significantly to this sequence. These data suggest that a function of p53 may be mediated by its ability to bind to specific DNA sequences in the human genome, and that this activity is altered by mutations that occur in human tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2047879     DOI: 10.1126/science.2047879

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  296 in total

1.  The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53.

Authors:  C Gobert; A Skladanowski; A K Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

Authors:  R Zhao; K Gish; M Murphy; Y Yin; D Notterman; W H Hoffman; E Tom; D H Mack; A J Levine
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

3.  Identification of partial loss of function p53 gene mutations utilizing a yeast-based functional assay.

Authors:  G K Kovvali; B Mehta; C B Epstein; S G Lutzker
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

Review 4.  Demystified ... p53.

Authors:  S J Darnton
Journal:  Mol Pathol       Date:  1998-10

5.  Activation of p53 protein by telomeric (TTAGGG)n repeats.

Authors:  M Milyavsky; A Mimran; S Senderovich; I Zurer; N Erez; I Shats; N Goldfinger; I Cohen; V Rotter
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

6.  ZBP-89 promotes growth arrest through stabilization of p53.

Authors:  L Bai; J L Merchant
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter.

Authors:  Takahito Nakagawa; Masato Takahashi; Toshinori Ozaki; Ken-ichi Watanabe Ki; Satoru Todo; Hiroyuki Mizuguchi; Takao Hayakawa; Akira Nakagawara
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

8.  Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo.

Authors:  M Doubrovin; V Ponomarev; T Beresten; J Balatoni; W Bornmann; R Finn; J Humm; S Larson; M Sadelain; R Blasberg; J Gelovani Tjuvajev
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

9.  Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis.

Authors:  J G Einspahr; D S Alberts; J A Warneke; P Bozzo; J Basye; T M Grogan; M A Nelson; G T Bowden
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

10.  Methylation of RASSF1A gene promoter is regulated by p53 and DAXX.

Authors:  Hailong Zhang; Jing He; Jiansha Li; Dan Tian; Lubing Gu; Muxiang Zhou
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.